← Leaderboards
Jevgenia Zilberman-Rudenko
Oregon Health & Science University
$161,420
Attributed
$161,420
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$161,420 · 1
By mechanism
F31$161,420 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Owen J McCarty$13,437,961
- Monica T Hinds$9,084,363
- Joseph James Shatzel$1,526,714
- Rick Mathews$212,958
- Wohaib Hasan$1,736,000
Others in their field
Other Emerging Leaders on “Apolipoprotein E Receptor 2”
- Gregory Scott Day · Washington University$4,080,222
- Jie Gao · University Of California Los Angeles$3,890,431
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$3,739,378
- Uwe Beffert · Boston University (Charles River Campus)$3,207,865
- Jan Johansson · Artery Therapeutics, Inc.$2,855,667
- Sarah Ann Flowers · Georgetown University$2,682,217
Research focus
Apolipoprotein E Receptor 2AttenuatedBacteriaBindingBlocking AntibodiesBlood CirculationBlood Coagulation FactorBlood PlateletsBlood VesselsCell WallChargeCoagulation ProcessCompetenceConsequentialismConsumptionDeep Vein ThrombosisDisseminated Intravascular CoagulationDissociationDistalEndothelial CellsEndothelial DysfunctionEndotheliumEnzymesAffect
Grant awards (4)
Role of FXI in Thrombohemorrhagic Complications$12,836
F31 · FY2020 · HL · contact PI
Role of FXI in Thrombohemorrhagic Complications$50,016
F31 · FY2019 · HL · contact PI
Role of FXI in Thrombohemorrhagic Complications$49,524
F31 · FY2018 · HL · contact PI
Role of FXI in Thrombohemorrhagic Complications$49,044
F31 · FY2017 · HL · contact PI